1               Documented IgE reactions, i.e. anaphylactoid, are quite rare (fewer than 1%).

2  element of anaphylactic (IgE-dependent) and anaphylactoid (IgE-independent) reactions.

3  of severe adverse effects, indicative of an anaphylactoid-like response.

4 osanoid may also influence the production of anaphylactoid lipids (e.g., PAF), arachidonic acid metab

5                                              Anaphylactoid reactions are common clinical acute advers

6 This LAD2 release model was used to evaluate anaphylactoid reactions induced by ciprofloxacin, norflo

7                                      She had anaphylactoid reactions on administration of intravenous

8         All 14 patients with anaphylactic or anaphylactoid reactions survived.

9 pplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intrave

10                                       Severe anaphylactoid reactions were recorded in five patients a

11 ine regimen resulted in less vomiting, fewer anaphylactoid reactions, and reduced need for treatment

12 les of MRGPRX2 on host defense, drug-induced anaphylactoid reactions, neurogenic inflammation, pain,

13 us events, such as seizures, anaphylactic or anaphylactoid reactions, serum sickness, and thrombocyto

14 tablish a novel method to evaluate drugs for anaphylactoid reactions.

15 amma receptor (FcgammaR) IIa in IVIg-induced anaphylactoid reactions.

16 e potential and strength of allergen-induced anaphylactoid reactions.

17 ation of drugs or components that may induce anaphylactoid reactions.

18 associated with systemic pseudo-allergic, or anaphylactoid, reactions; we show that drug-induced symp

19 tions; we show that drug-induced symptoms of anaphylactoid responses are significantly reduced in kno

20 in lots of heparin have been associated with anaphylactoid-type reactions resulting from contaminatio